Black Diamond Therapeutics Inc. (NASDAQ: BDTX) Stock Information | RedChip

Black Diamond Therapeutics Inc. (NASDAQ: BDTX) Listen to this Section


$4.98
-0.0200 ( -0.40% ) 351.2K

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Market Data


Open


$4.98

Previous close


$5.00

Volume


351.2K

Market cap


$281.39M

Day range


$4.94 - $5.22

52 week range


$1.62 - $7.66

Insider Ownership Transactions

Total Amount Purchased: -251,599.00 | $ -1,252,963.02

Date Type Amount Purchased Purchaser
2024-06-21 Sale -2011.00 Campbell Shannon
2024-06-21 Sale -2887.00 Behbahani Ali
2024-06-21 Sale -2301.00 Raman Prakash
2024-06-06 Sale -30550.00 Menzel Garry E
2024-06-06 Sale -30550.00 Behbahani Ali
2024-06-06 Sale -30550.00 Campbell Shannon
2024-06-06 Sale -30550.00 Raman Prakash
2024-06-06 Sale -30550.00 Dhingra Kapil
2024-06-06 Sale -30550.00 Kulkarni Samarth
2024-04-12 Sale -61100.00 Raman Prakash

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 06, 2024
10-q Quarterly Reports 62 Aug 06, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 2 Jun 06, 2024
4 Insider transactions 1 Jun 06, 2024
4 Insider transactions 1 Jun 06, 2024
4 Insider transactions 1 Jun 06, 2024
4 Insider transactions 1 Jun 06, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.